St. Jude’s Children’s Research Hospital has achieved a 94% survival rate in some types of cancer patients it treats, up from single digits when it opened in 1962. Health professionals have hailed the results as a remarkable achievement, helping save thousands of lives in the process.
Based in Memphis, TN, St. Jude’s Children’s Research Hospital has been working to develop treatment protocols for the most common forms of childhood cancer. With a focus on increasing survival rates, the hospital has posted strong performance. Many other cancer treatment facilities are expected to build on the strength of the results at St. Jude’s, with a view to helping more children and families recover from the cancer that affects their lives.
Image source: http://www.newswise.com/images/uploads/2010/06/8/NewswiseImage.jpg
Ongoing research work at the hospital is being targeted in genetics, in particular searching for more effective treatments for those suffering from various cancer types. Working with six partner hospitals nationwide, St. Jude’s facilitates the treatment of over 5,400 patients annually.
According to the Pediatric Genome Cancer Project, St. Jude’s Children’s Research Hospital is one the leading facilities for the research and treatment of pediatric cancers in the US, helping children from across the world fight back against cancer.
“St. Jude Children’s Research Hospital is internationally recognized for its pioneering research and treatment of children with cancer and other catastrophic diseases. Ranked the No. 1 pediatric cancer hospital by Parents magazine, St. Jude is the first and only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children and has treated children from all 50 states and from around the world.”
“Discoveries made at St. Jude have changed how the world treats children with cancer and other catastrophic diseases. With research and patient care under one roof, St. Jude is where some of today’s most gifted researchers are able to do science more quickly and a place where many doctors send some of their sickest patients and toughest cases.”
Image source: http://wac.450f.edgecastcdn.net/80450F/973thedawg.com/files/2013/05/st-jude-hospital.jpg
The results from St. Jude’s Children’s Research Hospital underline the possibilities for treatment in cancer through better research. Decades of research work and refining treatment processes have helped the hospital save countless thousands of children from cancer, in addition to giving clues as to the most effective methods for treating this kind of illness.
Chief Executive Officer of DeFoe Corp. John Amicucci is a supporter of the work done by the St. Jude’s Children’s Research Hospital, helping champion the hospital’s drive for independent support. Over several decades, the hospital has proven itself to be an effective provider of cancer care, with massive strides in survival rates helping save many more lives in the process.
Private funding from executives and philanthropists plays a key role in paying for St. Jude’s and its continued research efforts into childhood cancers. Its international profile makes it one of the most highly rated destinations for specialist pediatric cancer care in the world. With leading personnel in cancer research and treatments, it remains to be seen what St. Jude’s can achieve in future with further research and support.